Stock Events

Stock Events

Quoin Pharmaceuticals

€0

0

-€215.04-100% Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2EB0.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with Quoin Pharmaceuticals in the development and marketing of medications across various therapeutic areas.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment, competes in developing drugs that could directly compete with Quoin's product offerings.

Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals that can be in direct competition with Quoin Pharmaceuticals' products.

AbbVie operates in similar therapeutic areas as Quoin Pharmaceuticals, making it a competitor in the pharmaceutical industry.

Amgen is a biopharmaceutical company that competes with Quoin Pharmaceuticals in the development of innovative therapies.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose range of products competes with those of Quoin Pharmaceuticals.

Gilead Sciences

Gilead Sciences is involved in the research and development of pharmaceuticals that could compete with Quoin Pharmaceuticals in certain therapeutic areas.

Novartis is a global healthcare company that competes with Quoin Pharmaceuticals through its broad range of pharmaceutical products.

Roche Holding AG competes with Quoin Pharmaceuticals in the development and marketing of various pharmaceutical products.

Sanofi is a global pharmaceutical company that competes with Quoin Pharmaceuticals in several therapeutic areas, including rare diseases and immunology.

About

Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.

Show more...

CEO

Dr. Michael Myers Ph.D.

Employees

3

Country

Germany

ISIN

US74907L4095

Listings

0 Comments

Share your thoughts

FAQ

What is Quoin Pharmaceuticals stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Quoin Pharmaceuticals stocks are traded under the ticker 2EB0.STU.

Is Quoin Pharmaceuticals stock price growing?▼

2EB0.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Quoin Pharmaceuticals has showed a +0% increase.

How many employees does Quoin Pharmaceuticals have?▼

As of April 11, 2026, the company has 3 employees.

In which sector is Quoin Pharmaceuticals located?▼

Quoin Pharmaceuticals operates in the Health & Wellness sector.

When did Quoin Pharmaceuticals complete a stock split?▼

Quoin Pharmaceuticals has not had any recent stock splits.

Where is Quoin Pharmaceuticals headquartered?▼

Quoin Pharmaceuticals is headquartered in Ashburn, Germany.